Do you know the characteristics of cognitive disorders in people who are HIV positive? Do you know the pathogenesis of this neurocognitive decline?    Credit available for this activity expires: 10/25/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997643?ecd=bdc_podcast_libsyn_mscpedu

Latest real-world evidence with long-durability therapies for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME).

Credit available for this activity expires: 10/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997563?ecd=bdc_podcast_libsyn_mscpedu

Do you know which high-resolution computed tomography (HRCT) patterns are associated with fibrosing interstitial lung disease and its progression?

Credit available for this activity expires: 10/24/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/995581?ecd=bdc_podcast_libsyn_mscpedu

Find out from expert Dr Saye Khoo how to manage COVID-19 drug-drug interactions (DDIs).    Credit available for this activity expires: 10/20/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997480?ecd=bdc_podcast_libsyn_mscpedu

Did you know that noncellular CD19-targeted therapies represent a new therapeutic option in both transplant eligible and ineligible relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL)?

Credit available for this activity expires: 10/18/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997427?ecd=bdc_podcast_libsyn_mscpedu

Did you know that the latest guidelines for Waldenström macroglobulinemia now encompass second-generation Bruton tyrosine kinase inhibitors?

Credit available for this activity expires: 10/16/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997311?ecd=bdc_podcast_libsyn_mscpedu

Do you know who should be prioritized for dengue vaccination in different settings?

Credit available for this activity expires: 10/9/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997102?ecd=bdc_podcast_libsyn_mscpedu

Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF).    Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996906?ecd=bdc_podcast_libsyn_mscpedu

Expert tips to better select treatments, implement, and talk with patients.    Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996660?ecd=bdc_podcast_libsyn_mscpedu

Do you know about the extra cardiac effects and other effects of angiotensin receptor-neprilysin inhibitors (ARNIs)?    Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996323?ecd=bdc_podcast_libsyn_mscpedu